Description
Properdistatin Peptide (Highly Pure)
| Catalog number: | B2012818 |
| Lot number: | Batch Dependent |
| Expiration Date: | Batch dependent |
| Amount: | 500 ug |
| Molecular Weight or Concentration: | N/A |
| Supplied as: | Lyophilized Powder |
| Applications: | molecular tool for various biochemical applications |
| Storage: | -20C |
| Keywords: | Synthetic Peptide |
| Grade: | Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity>18 M-cm) and are filtered through 0.22 um. |
References
- Tomaszewski M, Stpie KM, Tomaszewska J, Czuczwar SJ. Statin-induced myopathies Pharmacol Rep. 2011;63(4):859-66.
- Abd TT, Jacobson TA. Statin-induced myopathy: a review and update Expert Opin Drug Saf. 2011 May;10(3):373-87.
- Zhao W, Xiao ZJ, Zhao SP. The Benefits and Risks of Statin Therapy in Ischemic Stroke: A Review of the Literature Neurol India. 2019 Jul-Aug;67(4):983-992.
- Koch CG. Statin therapy Curr Pharm Des. 2012;18(38):6284-90.
- Bellosta S, Corsini A. Statin drug interactions and related adverse reactions: an update Expert Opin Drug Saf. 2018 Jan;17(1):25-37.
- Istvan ES, Deisenhofer J. Structural mechanism for statin inhibition of HMG-CoA reductase Science. 2001 May 11;292(5519):1160-4.
- Graversen CB, Larsen ML, Schmidt EB. [Statin intolerance] Ugeskr Laeger. 2015 Aug 31;177(36):V03150271.
- Lamprecht DG Jr, Saseen JJ, Shaw PB. Clinical conundrums involving statin drug-drug interactions Prog Cardiovasc Dis. 2022 Nov-Dec;75:83-89.
- Awad K, Serban MC, Penson P, Mikhailidis DP, Toth PP, Jones SR, Rizzo M, Howard G, Lip GYH, Banach M; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group. Effects of morning vs evening statin administration on lipid profile: A systematic review and meta-analysis J Clin Lipidol. 2017 Jul-Aug;11(4):972-985.e9.
